Clinical trial

Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive…

NCT00484822 · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Other · Terminated

Key facts

NCT number NCT00484822
Title Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
Official title Multicentric, Randomized, Controlled, Double-blind Clinical Trial to Assess Perioperative Bridging Therapy With Sodium Bemiparin vs Calcium Unfractionated Heparin in Invasive Procedures, Outpatient Surgery and Laparoscopy Surgery in Patients Receiving Long-term Oral Anticoagulant Therapy
Acronym BERTA
Lead sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Other
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Long-term Oral Anticoagulant Therapy
Intervention type Drug
Interventions Bemiparina Sodica, Heparina Cálcica
Enrollment 206
Start date Feb 1, 2007
Completion May 1, 2009
First posted Jun 11, 2007
Last update posted Feb 4, 2010
Countries Spain

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies